Premium
Chemical safety, health care costs and the Affordable Care Act
Author(s) -
Landrigan Philip J.,
Goldman Lynn R.
Publication year - 2014
Publication title -
american journal of industrial medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 104
eISSN - 1097-0274
pISSN - 0271-3586
DOI - 10.1002/ajim.22268
Subject(s) - legislation , medicine , agency (philosophy) , health care , chemical safety , environmental health , public health , occupational safety and health , public administration , law , nursing , political science , risk analysis (engineering) , pathology , philosophy , epistemology
On May 22, 2013, the late Senator Frank Lautenberg (D‐NJ), Senator David Vitter (R‐LA) and 19 of their colleagues introduced bipartisan chemical safety legislation in the US Senate, “The Chemical Safety Improvement Act of 2013.” The bill's purpose is to protect human health and the environment against the hazards of toxic chemicals, by requiring the US Environmental Protection Agency (EPA) to examine the safety of all chemicals in consumer products. The bill is currently before the Senate Committee on Environment and Public Works, chaired by Senator Barbara Boxer (D‐CA). This legislation is critically important for physicians and healthcare organizations because it creates significant new opportunities to prevent disease and cut healthcare costs. Am. J. Ind. Med. 57:1–3, 2014. © 2013 Wiley Periodicals, Inc.